(HealthDay News) — Appropriate use criteria (AUC) for the use of amyloid and tau positron emission tomography (PET) have been issued by the Alzheimer’s Association and the Society for Nuclear Medicine ...
Nuclear imaging market set for steady growth at 3.87% CAGR from 2024 to 2032, fueled by rising chronic disease prevalence and AI-driven innovations. Akash Anand SNS Insider Pvt. Ltd 415-230-0044 email ...
Lantheus is acquiring radiopharmaceutical CDMO Evergreen Theragnostics in a deal worth up to $1 billion, expanding its manufacturing capabilities and drug pipeline. The acquisition includes Octevy, a ...